A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Imatinib Impurity 21 | CAS 110928-44-4 - Request Quote

Picture of Imatinib Impurity 21

Imatinib Impurity 21

SZ CAT No:SZ-I004054
CAS No
110928-44-4
Mol.F.
C9H16O3
Mol.Wt.
172.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Imatinib Impurity 21 is chemically Methyl 4-(Hydroxymethyl)cyclohexanecarboxylate. Imatinib Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Imatinib Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Imatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 110928-44-4

Purchase 110928-44-4

Order 110928-44-4

Enquire 110928-44-4

price of 110928-44-4

110928-44-4 Supplier

110928-44-4 Manufacturer

110928-44-4 Exporter

buy high quality Imatinib Impurity 21

Purchase Imatinib Impurity 21

Imatinib Impurity 21 suppliers

Imatinib Impurity 21 manufacturers

Imatinib Impurity 21 price

Order Imatinib Impurity 21

Enquire Imatinib Impurity 21

Imatinib Impurity 21 cost

Imatinib Impurity 21 Supplier

Imatinib Impurity 21 Distributor

Imatinib Impurity 21 for Method Validation

Imatinib Reference Standard

Imatinib Impurity 21 for ANDA Filing

Imatinib Impurity 21 for Forced Degradation Studies

Imatinib Impurity 21 Identification Standards

Imatinib Impurity 21 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,